Blog

In the latest news involving the immunotherapy drug Keytruda, companies have combined their efforts to fight mesothelioma. As reported earlier, the FDA recently opened the door for combining immunotherapy drugs with other approved treatments. Worldwide, treatments using a combined approach are seeing promising results. Now Merck, the marketer of Keytruda, has joined forces with the » Read More

A 64-year-old widow living in Newcastle, UK, was left shocked after she was diagnosed with mesothelioma last year. She had never worked around asbestos, which is the underlying cause of mesothelioma. She could not imagine how she caught the cancer until she recalled that her husband used to bring home his dusty clothing to be » Read More

Researchers from Antwerp and Ghent University Hospitals are making strides toward finding better ways of diagnosing mesothelioma by employing breathomics to help detect early signs of the disease. Breathomics is the scientific name for breath analysis, and involves using an artificial nose or tests to detect mesothelioma biomarkers in the blood. Mesothelioma is a very » Read More

Immunotherapy as an effective treatment for mesothelioma has made international news. Ketruda, a leading brand in the fight against cancer has been attributed with successes in both England and the United States. Although immunotherapy as a cancer treatment is not entirely new, research into its use has escalated. Researchers are discovering that these drugs have » Read More